Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 3878 | 15.62 |
09:34 ET | 1000 | 15.6 |
09:36 ET | 800 | 15.61 |
09:38 ET | 500 | 15.5342 |
09:39 ET | 700 | 15.5737 |
09:41 ET | 1610 | 15.7 |
09:43 ET | 1300 | 15.675 |
09:45 ET | 1601 | 15.7 |
09:48 ET | 632 | 15.6979 |
09:50 ET | 1929 | 15.73 |
09:52 ET | 2059 | 15.75 |
09:54 ET | 1750 | 15.74 |
09:56 ET | 8626 | 15.78 |
09:57 ET | 30500 | 15.75 |
09:59 ET | 1824 | 15.749 |
10:01 ET | 1371 | 15.84 |
10:03 ET | 19100 | 15.73 |
10:06 ET | 201 | 15.69 |
10:08 ET | 404 | 15.69 |
10:10 ET | 300 | 15.65 |
10:12 ET | 5194 | 15.6648 |
10:14 ET | 376 | 15.73 |
10:15 ET | 474 | 15.77 |
10:17 ET | 1681 | 15.87 |
10:21 ET | 156 | 15.86 |
10:24 ET | 226 | 15.82 |
10:26 ET | 200 | 15.74 |
10:30 ET | 500 | 15.695 |
10:33 ET | 1196 | 15.7 |
10:35 ET | 214 | 15.75 |
10:37 ET | 202 | 15.78 |
10:42 ET | 102 | 15.79 |
10:44 ET | 496 | 15.79 |
10:48 ET | 603 | 15.82 |
10:50 ET | 100 | 15.83 |
10:51 ET | 220 | 15.85 |
10:53 ET | 839 | 15.93 |
10:55 ET | 100 | 15.92 |
10:57 ET | 4502 | 15.99 |
11:00 ET | 1156 | 16.05 |
11:02 ET | 502 | 16.12 |
11:06 ET | 1035 | 16.17 |
11:08 ET | 33188 | 16.14 |
11:11 ET | 2341 | 16.23 |
11:13 ET | 822 | 16.29 |
11:15 ET | 1213 | 16.23 |
11:18 ET | 1550 | 16.19 |
11:20 ET | 6540 | 16.17 |
11:22 ET | 1040 | 16.115 |
11:24 ET | 200 | 16.05 |
11:26 ET | 102507 | 15.985 |
11:27 ET | 500 | 15.99 |
11:29 ET | 100 | 15.99 |
11:31 ET | 35972 | 15.99 |
11:33 ET | 100 | 16.02 |
11:36 ET | 1160 | 15.97 |
11:38 ET | 1004 | 15.93 |
11:40 ET | 100 | 15.94 |
11:42 ET | 200 | 15.95 |
11:44 ET | 100 | 15.97 |
11:45 ET | 300 | 15.955 |
11:47 ET | 200 | 15.98 |
11:49 ET | 967 | 16 |
11:51 ET | 2456 | 16.025 |
11:54 ET | 1500 | 16.08 |
11:56 ET | 900 | 16.072 |
12:00 ET | 100 | 16.07 |
12:02 ET | 104 | 16.06 |
12:03 ET | 400 | 16.09 |
12:05 ET | 2000 | 16.07 |
12:07 ET | 294 | 16.14 |
12:09 ET | 100 | 16.15 |
12:14 ET | 100 | 16.17 |
12:16 ET | 100 | 16.18 |
12:18 ET | 685 | 16.21 |
12:20 ET | 836 | 16.18 |
12:21 ET | 200 | 16.2 |
12:23 ET | 300 | 16.2 |
12:25 ET | 809 | 16.195 |
12:27 ET | 676 | 16.2 |
12:30 ET | 404 | 16.21 |
12:32 ET | 200 | 16.195 |
12:34 ET | 2334 | 16.185 |
12:36 ET | 538 | 16.19 |
12:38 ET | 200 | 16.21 |
12:39 ET | 100 | 16.22 |
12:41 ET | 300 | 16.23 |
12:43 ET | 516 | 16.15 |
12:45 ET | 784 | 16.14 |
12:48 ET | 580 | 16.13 |
12:50 ET | 1031 | 16.1 |
12:52 ET | 100 | 16.12 |
12:54 ET | 1332 | 16.11 |
12:56 ET | 100 | 16.12 |
12:59 ET | 200 | 16.16 |
01:01 ET | 409 | 16.12 |
01:06 ET | 300 | 16.11 |
01:10 ET | 500 | 16.13 |
01:12 ET | 200 | 16.14 |
01:14 ET | 3904 | 16.18 |
01:15 ET | 100 | 16.24 |
01:19 ET | 200 | 16.215 |
01:21 ET | 100 | 16.24 |
01:24 ET | 272 | 16.216 |
01:26 ET | 3185 | 16.16 |
01:28 ET | 652 | 16.18 |
01:32 ET | 246 | 16.18 |
01:35 ET | 300 | 16.22 |
01:37 ET | 100 | 16.23 |
01:39 ET | 734 | 16.2 |
01:44 ET | 651 | 16.24 |
01:46 ET | 200 | 16.26 |
01:48 ET | 200 | 16.23 |
01:50 ET | 557 | 16.24 |
01:51 ET | 301 | 16.25 |
01:53 ET | 1011 | 16.2 |
01:55 ET | 100 | 16.23 |
01:57 ET | 345 | 16.205 |
02:00 ET | 100 | 16.23 |
02:02 ET | 420 | 16.22 |
02:04 ET | 337 | 16.23 |
02:06 ET | 100 | 16.24 |
02:08 ET | 539 | 16.2 |
02:09 ET | 200 | 16.25 |
02:11 ET | 100 | 16.26 |
02:13 ET | 200 | 16.27 |
02:15 ET | 100 | 16.27 |
02:18 ET | 200 | 16.28 |
02:20 ET | 1362 | 16.3 |
02:22 ET | 1716 | 16.3 |
02:24 ET | 300 | 16.32 |
02:26 ET | 1911 | 16.35 |
02:27 ET | 100 | 16.36 |
02:29 ET | 678 | 16.39 |
02:31 ET | 312 | 16.36 |
02:33 ET | 300 | 16.36 |
02:36 ET | 400 | 16.39 |
02:38 ET | 100 | 16.38 |
02:40 ET | 325 | 16.39 |
02:44 ET | 200 | 16.41 |
02:45 ET | 1830 | 16.42 |
02:47 ET | 100 | 16.42 |
02:49 ET | 809 | 16.38 |
02:51 ET | 1592 | 16.415 |
02:56 ET | 400 | 16.44 |
02:58 ET | 100 | 16.45 |
03:00 ET | 945 | 16.48 |
03:02 ET | 1200 | 16.47 |
03:03 ET | 1263 | 16.49 |
03:05 ET | 500 | 16.49 |
03:07 ET | 843 | 16.5 |
03:12 ET | 4905 | 16.47 |
03:14 ET | 1119 | 16.45 |
03:16 ET | 1600 | 16.45 |
03:18 ET | 325 | 16.46 |
03:20 ET | 849 | 16.45 |
03:23 ET | 2070 | 16.49 |
03:25 ET | 922 | 16.495 |
03:27 ET | 856 | 16.5 |
03:30 ET | 1456 | 16.54 |
03:32 ET | 967 | 16.52 |
03:34 ET | 1302 | 16.51 |
03:36 ET | 400 | 16.49 |
03:38 ET | 3508 | 16.46 |
03:39 ET | 2890 | 16.48 |
03:41 ET | 300 | 16.465 |
03:43 ET | 12505 | 16.51 |
03:45 ET | 1661 | 16.53 |
03:48 ET | 26722 | 16.55 |
03:50 ET | 5215 | 16.55 |
03:52 ET | 8268 | 16.57 |
03:54 ET | 4444 | 16.575 |
03:56 ET | 4313 | 16.595 |
03:57 ET | 5465 | 16.581 |
03:59 ET | 99098 | 16.65 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.4B | -5.4x | --- |
WAVE Life Sciences Ltd | 1.2B | -14.5x | --- |
Ardelyx Inc | 1.6B | -24.5x | --- |
Nurix Therapeutics Inc | 1.4B | -7.6x | --- |
Gyre Therapeutics Inc | 1.1B | -15.6x | --- |
Xencor Inc | 1.4B | -6.9x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $247.0M |
Shares Outstanding | 91.4M |
Arcus Biosciences Inc does not pay a dividend. | |
Beta | 0.89 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -5.4x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -118.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.